CYCC - Cyclacel Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2017)Next Qtr. (Jun 2017)Current Year (2017)Next Year (2018)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS-0.96-1.2N/AN/A
Revenue EstimateCurrent Qtr. (Mar 2017)Next Qtr. (Jun 2017)Current Year (2017)Next Year (2018)
No. of Analysts0011
Avg. EstimateN/AN/A2M2M
Low EstimateN/AN/A2M2M
High EstimateN/AN/A2M2M
Year Ago SalesN/AN/A843k2M
Sales Growth (year/est)N/AN/A137.20%0.00%
Earnings History9/29/201512/30/20159/29/201612/30/2016
EPS Est.-1.08-0.96-0.94-0.73
EPS Actual-0.96-1.2-0.86-0.69
Difference0.12-0.240.080.04
Surprise %11.10%-25.00%8.50%5.50%
EPS TrendCurrent Qtr. (Mar 2017)Next Qtr. (Jun 2017)Current Year (2017)Next Year (2018)
Current Estimate0000
7 Days Ago00-2.25-1.57
30 Days Ago00-2.25-1.57
60 Days Ago00-2.25-1.57
90 Days Ago00-2.25-1.57
EPS RevisionsCurrent Qtr. (Mar 2017)Next Qtr. (Jun 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesCYCCIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.15
Next Qtr.N/AN/AN/A0.27
Current YearN/AN/AN/A0.07
Next YearN/AN/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A